Schizophrenia trials recruiting in Connecticut

All Schizophrenia trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Study of Brenipatide in Adult Participants With Schizophrenia
  NCT07410507 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Connecticut: Hartford, New Haven
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Connecticut: Farmington
• A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
  NCT07424404 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · Connecticut: New Haven
• Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
  NCT06740383 · Phase: Not specified · Ages: 18 Years to 40 Years · Sex: All (male and female) · Connecticut: Hartford
• CLOZAPINE Response in Biotype-1
  NCT04580134 · Phase: Phase 4 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Connecticut: Hartford
• Genetic Basis of the Risk and Consequences of Cannabis Exposure in Humans
  NCT06058702 · Phase: Phase 1 · Ages: 21 Years to 60 Years · Sex: All (male and female) · Connecticut: West Haven
• Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
  NCT01730781 · Phase: Not specified · Ages: 18 Years to 55 Years · Sex: Male · Connecticut: New Haven
• MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction
  NCT06191965 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 35 Years · Sex: All (male and female) · Connecticut: New Haven
• SV2 PET Imaging With [11C]APP311
  NCT03995121 · Phase: Not specified · Ages: 18 Years to 85 Years · Sex: All (male and female) · Connecticut: New Haven
• Social Isolation and Aging in Schizophrenia
  NCT07419321 · Phase: Not specified · Ages: 40 Years to 70 Years · Sex: All (male and female) · Connecticut: Hartford
• Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
  NCT05303064 · Phase: Phase 3 · Ages: 10 Years to 17 Years · Sex: All (male and female) · Connecticut: Hartford
• Toward a Computationally-Informed, Personalized Treatment for Hallucinations
  NCT04366518 · Phase: Early Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Connecticut: New Haven